BDBM328797 1,1,1-trifluoro-2-methylpropan- 2-yl ((S)-4-((1- (difluoromethyl)-3-ethoxy-1H- pyrazol-4-yl)sulfonyl)-2- (((1S,2S)-2- fluorocyclopropane- carboxamido)methyl)-3,4- dihydro-2H- benzo[b][1,4]oxazin-6- yl)carbamate::US9663502, 34CY

SMILES CCOc1nn(cc1S(=O)(=O)N1C[C@H](CNC(=O)[C@@H]2C[C@@H]2F)Oc2ccc(NC(=O)OC(C)(C)C(F)(F)F)cc12)C(F)F

InChI Key InChIKey=QQUKTKJIVGHERC-ZNMIVQPWSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 328797   

TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Lycera

US Patent
LigandPNGBDBM328797(1,1,1-trifluoro-2-methylpropan- 2-yl ((S)-4-((1- (...)
Affinity DataIC50:  3.07nMAssay Description:The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., a biochemical TR-FRET assay....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent